Rheumatologist’s Perception of the Efficacy, Safety and Willingness to Prescribe Infliximab and Use Alternate Drug Supply Programs to Lower Cost of Rheumatoid Arthritis Care Michele Hamburger, MA – Frances Hamburger Institute
9:00 AM – 11:00 AM ET
Clinical Timelines and Management Delays in Suspected Giant Cell Arteritis Cindy Chiu, DO – Virginia Mason Medical Center
9:00 AM – 11:00 AM ET
Ability and Willingness to Utilize Telemedicine Among Rheumatology Patients – a Cross Sectional Survey Lilian Otalora Rojas, MD – Department of Internal Medicine, University of Central Florida College of Medicine, Orlando, FL
9:00 AM – 11:00 AM ET
The Patient Perspective on Using Digital Resources to Address Unmet Needs in Systemic Lupus Erythematosus Jennifer H. Ra, BA – Washington University School of Medicine
9:00 AM – 11:00 AM ET
Improving Care for Patients with Inflammatory Arthritis by Enabling Physical Therapists to Directly Refer to Rheumatologists: A Qualitative Study Debbie Feldman, PhD, PT – University of Montreal
9:00 AM – 11:00 AM ET
Two-year Cost-effectiveness Between Two Gradual Tapering Strategies in Rheumatoid Arthritis: Cost-utility Analysis of the TARA Trial Elise van Mulligen, MSc – Erasmus MC
9:00 AM – 11:00 AM ET
Effects of Successive Switches of Two Different Biosimilars of Etanercept on Outcomes in Inflammatory Rheumatic Diseases in Daily Practice Uta Kiltz, MD – Rheumazentrum Ruhrgebiet, Ruhr-University Bochum
9:00 AM – 11:00 AM ET
Is Hydroxychloroquine Use a Proxy for Health Care Access? Predictors of First Dispensing Among Medicaid Beneficiaries with Incident Lupus Katherine Pryor, MD – Brigham and Women's Hospital
9:00 AM – 11:00 AM ET
The Impact of an Integrated Care Management Program on Acute Care Utilization and Outpatient Appointment Attendance Among High-Risk Patients with Lupus Jessica Williams, MD, MPH – Brigham and Women's Hospital
9:00 AM – 11:00 AM ET
Cost-effectiveness of Motivational Counselling and SMS-reminders on Daily Sitting Time in Patients with Rheumatoid Arthritis Jan Sorensen, MSc – Healthcare Outcomes Research Centre
9:00 AM – 11:00 AM ET
Performance Characteristics of ANA by Elisa and Immunofluorescence Gitanjali Lobo, MD – TriHealth Good Samaritan Hospital
9:00 AM – 11:00 AM ET
Barriers to Rheumatologic Care and Antimalarial Refills Among a Cohort of Patients with Systemic Lupus Erythematosus During the COVID-19 Pandemic ALFREDO AGUIRRE, MD – University of California, San Francisco
9:00 AM – 11:00 AM ET
Feast or Famine? An Institutional Assessment of Hydroxychloroquine Screening Practices Alanna E. James, MD, BS – Loma Linda University
9:00 AM – 11:00 AM ET
The Ideal Mhealth Application for Rheumatoid Arthritis: Qualitative Findings from Stakeholder Focus Groups Diederik De Cock, PhD – KU Leuven
9:00 AM – 11:00 AM ET
A Web-Based Data Capture System Can Successfully Collect Detailed and Quantifiable Physical Therapy Intervention Data Post Total Knee Replacement Carol Oatis, PhD, PT – Arcadia University
9:00 AM – 11:00 AM ET
Intervention to Improve SLE Medication Adherence Using Surescripts Pharmacy Refill Data Kai Sun, MD – Duke University
9:00 AM – 11:00 AM ET
A Rheumatology-Driven Protocol and Treatment Algorithm of SARS-CoV-2 Cytokine Release Syndrome and Its Associated Outcomes Sandy Lee, DO – Loma Linda University Medical Center
9:00 AM – 11:00 AM ET
Patient Characteristics and Factors Affecting Decision-Making Regarding Total Knee Replacement by Different Types of Physicians Treating Patients with Knee OA Timothy McAlindon, MD, MRCP, MPH – Tufts Medical Center
9:00 AM – 11:00 AM ET
Mechanical and Temperature Stress During Biologic Shipments to Rheumatology Patients Sarah Dill, MD – Virginia Mason Memorial & Pacific Northwest University
9:00 AM – 11:00 AM ET
High Satisfaction with Tele-medicine in a New York City Clinic Tommy K. Chen – Columbia University Medical Center
9:00 AM – 11:00 AM ET
Clinical Academic Rheumatology: A Boon for Health Systems Kathleena M. D'Anna, DO – Loma Linda University
9:00 AM – 11:00 AM ET
Telemedicine in Pediatric Rheumatology During COVID-19: The PR-COIN Experience Y. Ingrid Goh, PhD – The Hospital for Sick Children
9:00 AM – 11:00 AM ET
Impact of a Dedicated Lupus Nephritis Clinic to Improve Time to Biopsy and Care Quality Shivani Garg, MD, MS – UW Madison
9:00 AM – 11:00 AM ET
Evaluation of Telephone Consultations in Germany as an Additional Tool in Outpatient Rheumatology Clinics During the COVID-19 Pandemic Florian Meier, MD – University Hospital Frankfurt
9:00 AM – 11:00 AM ET
Gout Increases Length of Stay in Patients Hospitalized for Heart Failure Exacerbation Daniel J. DeMizio, MD – New York Presbyterian/Columbia
9:00 AM – 11:00 AM ET
The “Why” of Drug Discontinuation; Clinical Review of EMR Notes for 2,545 Patients with Rheumatic Diseases Kent Kwas Huston, MD – Kansas City Physician Partners
9:00 AM – 11:00 AM ET
WITHDRAWN
9:00 AM – 11:00 AM ET
Multisite Study of the Impact of COVID-19 Era Telemedicine Expansion on Reduction in No-Show Rates Christie M. Bartels, MD, MS – University of Wisconsin School of Medicine and Public Health
9:00 AM – 11:00 AM ET
Increasing the Rate of Pneumococcal Vaccination in an Academic Rheumatology Outpatient Clinic Maria A. Bacalao, MD – UT Southwestern
9:00 AM – 11:00 AM ET
How Did SARS-CoV2/COVID-19 Pandemic Affected Rheumatology Practice in Latin America? A Regional Survey from PANLAR Daniel Fernández-Ávila, MD, PhD, MSc – Pontificia Universidad Javeriana - Hospital Universitario San Ignacio
9:00 AM – 11:00 AM ET
A Systematic Review Exploring Pre-COVID-19 Telehealthcare Models Used in the Management of Patients with Rheumatological Disease Alexandra Nelson, -None- – University of Liverpool
9:00 AM – 11:00 AM ET
The Evolution of Rheumatologist's Practice in Response to the COVID19 Pandemic Maria A. Bacalao, MD – UT Southwestern
9:00 AM – 11:00 AM ET
Patient and Parent Perspectives in a Academic Pediatric Rheumatology Transition Clinic Rebecca S. Overbury, MD, MS – University of Utah
9:00 AM – 11:00 AM ET
Impact of Depressive Symptoms, Anti-depression Treatment on Direct Medical Costs Among Medicare Beneficiaries with Knee Osteoarthritis (KOA) Zoey Shuang Song, MPH – Brigham and Women's Hospital
9:00 AM – 11:00 AM ET
Change in Utilization of Outpatient Services at US Community Rheumatology Practices During COVID-19 Outbreak Kent Kwas Huston, MD – Kansas City Physician Partners
9:00 AM – 11:00 AM ET
Disease Activity and Disability Are Not Associated with Rehabilitation Utilization in African Americans with Rheumatoid Arthritis Louise M. Thoma, PhD, DPT – University of North Carolina
9:00 AM – 11:00 AM ET
Differences in 30-Day Rehospitalization Risk and Predictors by Age Group Among Patients with Lupus in Medicare Maria Schletzbaum, BA – University of Wisconsin School of Medicine and Public Health
9:00 AM – 11:00 AM ET
Modeling the Effects of Covid-19 Protective Behaviors and Healthcare Delivery on the Health of Patients with Rheumatic Disease Kevin Kennedy, MA – McMaster University
9:00 AM – 11:00 AM ET
Impact of COVID-19 Pandemic on the Rheumatology Practice in Mexico: Mexican College of Rheumatology Survey Deshire Alpizar-Rodriguez, MD, PhD – Mexican College of Rheumatology
9:00 AM – 11:00 AM ET
Rheumatology Going Digital: Developing a Rheumatology App for Use by All Patients Attending Our Department to Aid Remote Working and Self-management Kirsten Mackay, MD – Torbay and South Devon NHS Foundation Trust
9:00 AM – 11:00 AM ET
Correlation Between Disease Activity and Perceived Economic Barriers to Care in a Population of African American Women with Systemic Lupus Erythematosus Edith Williams, PhD – Medical University of South Carolina
9:00 AM – 11:00 AM ET
Support Methodologies for African American Women with Lupus – Comparing Two Study’s Effects on Patient Activation Edith Williams, PhD – Medical University of South Carolina
9:00 AM – 11:00 AM ET
The Effect of Travel Burden on Depression and Anxiety in African American Women Living with Systemic Lupus Edith Williams, PhD – Medical University of South Carolina
9:00 AM – 11:00 AM ET
WITHDRAWN
9:00 AM – 11:00 AM ET
Do Physical Therapists Follow Evidence-Based Practice Recommendations for Treatment of Inflammatory Arthritides? Debbie Feldman, PhD, PT – University of Montreal
9:00 AM – 11:00 AM ET
Medical Savings of Timely Rheumatoid Arthritis Diagnoses Michele Hamburger, MA – Frances Hamburger Institute
9:00 AM – 11:00 AM ET
Qualitative Review of Unsuccessful Pilot Study of Super-Utilizer Systemic Lupus Erythematosus (SLE) Patients Enrollment into Team Based Program to Improve Patient Outcomes Sarah Min, MD – The Christ Hospital
9:00 AM – 11:00 AM ET
Going Digital Due to COVID 19 Crisis: A Rapid Reorganisation of Medication Clinics Kirsten Mackay, MD – Torbay and South Devon NHS Foundation Trust
9:00 AM – 11:00 AM ET
Risk Factors of Nonadherence in New Rheumatoid Arthritis Patients Michele Hamburger, MA – Frances Hamburger Institute
9:00 AM – 11:00 AM ET
Risk of Severe Acute Localized Reactions for Different Intra-Articular Hyaluronic Acid Knee Injections in a Real World Setting Kevin L. Ong, PhD – Exponent, Inc.
9:00 AM – 11:00 AM ET
A Proposed Economic Framework to Model the Consequences of Psoriatic Arthritis Disease Domains Howard Thom, PhD – University of Bristol
9:00 AM – 11:00 AM ET
Mortality and Cost of Hospitalization: Do Hospitals Caring for More SLE Patients Perform Better? Christine Anastasiou, MD – University of California, San Francisco
9:00 AM – 11:00 AM ET
Cost of Illness in Patients with Psoriasis and Psoriatic Arthritis Santos Castañeda, PhD – Hospital Universitario de la Princesa
9:00 AM – 11:00 AM ET
Total Cost of Care for Patients with Rheumatoid Arthritis Michele Hamburger, MA – Frances Hamburger Institute
